News
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
Ohio to end GLP-1 drug coverage for most state workers without diabetes, citing soaring Medicaid costs and rising demand for ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
While the makers of Ozempic have stated that their GLP-1 medication was not made to be used as a weight loss drug, nor should ...
3d
Zacks Investment Research on MSNCan Ozempic, Wegovy Drive Further Growth for NVO in the Obesity Space?Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
1d
PhilStar Global on MSNFilipino psychiatrist debunks stigma: Obesity a health issue, not a character flawAccording to the Department of Science and Technology's Food and Nutrition Research Institute, around 27 million Filipinos ...
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.
Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 ...
Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...
4d
News-Medical.Net on MSNBariatric surgery leads to greater weight loss than GLP-1 drugs after two yearsSleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results